1. Home
  2. CMPS vs KOP Comparison

CMPS vs KOP Comparison

Compare CMPS & KOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$6.60

Market Cap

662.5M

Sector

Health Care

ML Signal

HOLD

Logo Koppers Holdings Inc.

KOP

Koppers Holdings Inc.

HOLD

Current Price

$30.14

Market Cap

536.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPS
KOP
Founded
2020
1988
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Forest Products
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
662.5M
536.4M
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
CMPS
KOP
Price
$6.60
$30.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
2
Target Price
$16.86
$52.50
AVG Volume (30 Days)
1.4M
126.8K
Earning Date
02-26-2026
02-26-2026
Dividend Yield
N/A
1.08%
EPS Growth
N/A
N/A
EPS
N/A
0.78
Revenue
N/A
$1,923,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.94
P/E Ratio
N/A
$37.88
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$22.99
52 Week High
$8.20
$35.61

Technical Indicators

Market Signals
Indicator
CMPS
KOP
Relative Strength Index (RSI) 44.99 63.40
Support Level $6.49 $28.99
Resistance Level $7.45 $30.22
Average True Range (ATR) 0.40 0.78
MACD -0.11 0.10
Stochastic Oscillator 15.02 78.42

Price Performance

Historical Comparison
CMPS
KOP

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About KOP Koppers Holdings Inc.

Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.

Share on Social Networks: